Free provider profile

MARISA HINE, NP

NPI 1881148930
Individual
Nurse Practitioner, Adult Health
Active registration
Save to rep workspaceFollow this provider Sign in to find emailNPI registry

Need more providers like MARISA HINE?

See the count and top 3 free, ranked by Medicare billing. Full list $29, included with membership.

Rep intel

What MARISA HINE prescribes and who else does

Top Medicare Part D drugs by claims (public CMS data):

  • Scemblix
  • Imatinib Mesylate
  • Sprycel
  • Jakafi
  • Calquence

See all nurse practitioners in NY who bill Medicare →

Your next referral list starts here

Provider + market indicator

A combined screening indicator—not a provider fraud-risk score. Local plan ratings describe the surrounding market, not this provider’s quality, plan membership or wrongdoing.

Comparing current CMS billing with peers and checking OIG and plan ratings… A new peer comparison can take about a minute.

Practice contact card

Practice phone

212-639-2000

Practice address

1275 YORK AVE, NEW YORK, NY, 10065

Registry updated
2016-08-06
NPI issued
2016-08-06
RepVector retrieved
11/21/2026

A recent retrieval can still contain an old address if the provider has not updated their registry record. Website email checks show their own date under Find email.

Registry record

Source: CMS NPPES registry.

1275 YORK AVE, NEW YORK, NY, 10065

212-639-2000

Single practice location

Enumerated 2016-08-06

  • — Registration is active in NPPES.
  • — Individual clinician record — reachable, but usually not the buyer.
  • — Practice phone number is published.
  • — Full street address on file for route planning.
  • — Record last updated 10 years ago.

Medicare Part D prescribing

Source: CMS Medicare Part D Prescribers by Provider, most recent public year.

Part D claims

697

Medicare patients

141

Part D drug cost

$6,567,293

Brand-name share

52.4%

of this prescriber's Part D claims

DrugClaimsMedicare cost
Scemblix (Asciminib Hydrochloride)74$1,522,646
Jakafi (Ruxolitinib Phosphate)54$907,169
Ojjaara (Momelotinib Dihydrochloride)23$731,168
Sprycel (Dasatinib)58$620,381
Calquence (Acalabrutinib Maleate)41$600,254
Gleevec (Imatinib Mesylate)18$358,054
Imatinib Mesylate (Imatinib Mesylate)72$335,471
Brukinsa (Zanubrutinib)18$265,374

Want their full drug mix and peer benchmark? Run the free Part D prescriber lookup.

Latest Medicare Part B billing

CMS Physician and Other Practitioners, by Provider and Service. New published billing years are detected daily, using the same release as the Billing analyst and risk maps.

Loading the latest published CMS billing file…

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

Checking Open Payments…

Industry payments across NY — which companies pay providers there.

Open Payments page for this provider

Tailored to Provider research.

Build the provider research list for one county and check the names yourself.

Name the city, county, or state. RepVector selects the datasets that matter for provider research, enriches each target with what its site publishes, and returns a scored list with phones, addresses and named contacts.

Build a provider research list

3 free runs — no card required.